NVCT - Nuvectis Pharma, Inc.

QQQ $ 454.54 $ 2.06 (0.46 %)

DIA $ 400.15 $ 0.27 (0.07 %)

SPY $ 530.91 $ 1.36 (0.26 %)

TLT $ 91.10 $ 0.04 (0.04 %)

GLD $ 224.34 $ 0.98 (0.44 %)

Previous Close

$ 6.15

Open

$ 6.07

Bid

$ 6.08 x 100

Ask

$ 0.00 x 0

Day's Range

$ 6.07 - $ 6.07

52 Week Range

$ 5.92 - $ 18.65

Volume

110,339

Average Volume

Market Cap

101.84M

Beta (5Y Monthly)

$ 0.07

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-07-2024	03-31-2024	10-Q
2	03-05-2024	12-31-2023	10-K
3	11-08-2023	09-30-2023	10-Q
4	08-09-2023	06-30-2023	10-Q
5	05-10-2023	03-31-2023	10-Q
6	03-08-2023	12-31-2022	10-K
7	11-08-2022	09-30-2022	10-Q
8	08-10-2022	06-30-2022	10-Q
9	05-12-2022	03-31-2022	10-Q
10	03-23-2022	12-31-2021	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

HC Wainwright & Co. Reiterates Buy on Nuve...
05/08/2024 19:03:40

HC Wainwright & Co. analyst Joseph Pantginis reiterates Nuvectis Pharma (NASDAQ:NVCT) with a Buy and maintains $21 price...

Nuvectis Pharma Q1 EPS $(0.25) Beats $(0.4...
05/07/2024 12:11:58

Nuvectis Pharma (NASDAQ:NVCT) reported quarterly losses of $(0.25) per share which beat the analyst consensus estimate of $(0.4...

Nuvectis Pharma's NXP900 Demonstrates Robu...
04/08/2024 12:41:45

Highly Synergistic Antiproliferative Activity in EGFR-resistant Cells in Combination with Osimertinib, the Active Ingredient in...

Nuvectis Pharma Announced 33% Response Rat...
03/14/2024 13:47:15

12-health-care-stocks-moving-in-thursdays-pre-market-session

12 Health Care Stocks Moving In Thursday's...
03/14/2024 13:06:15

Nuvectis Pharma Announces Preliminary Data...
03/14/2024 13:02:14

33% Response Rate and 100% Disease Control Rate Observed in Patients Evaluated for EfficacyComplete Response of Non-Target Tum...

Nuvectis Pharma, Inc. Reports Fiscal Year ...
03/05/2024 13:21:39

NUVECTIS PHARMA, INC.STATEMENT OF OPERATIONS(USD in thousands, except per share and share amounts)For the year endedFor the year

12-health-care-stocks-moving-in-thursdays-intraday-session

12 Health Care Stocks Moving In Thursday's...
01/18/2024 17:31:14

Nuvectis Pharma, Inc. Announces A Collabor...
12/18/2023 13:06:57

Mitesh Borad, M.D., will serve as the Principal Investigator for the clinical trialThe Investigator-sponsored clinical trial fo...

Nuvectis Pharma Q3 EPS $(0.37) Misses $(0....
11/08/2023 13:10:51

Nuvectis Pharma (NASDAQ:NVCT) reported quarterly losses of $(0.37) per share which missed the analyst consensus estimate of $(0...

Recap: Nuvectis Pharma Q3 Earnings
11/08/2023 13:10:06

12-health-care-stocks-moving-in-tuesdays-intraday-session

12 Health Care Stocks Moving In Tuesday's ...
10/17/2023 17:31:01

Nuvectis Pharma Announces Upcoming Present...
09/21/2023 12:01:20

HC Wainwright & Co. Reiterates Buy on Nuve...
09/15/2023 10:10:00

HC Wainwright & Co. analyst Joseph Pantginis reiterates Nuvectis Pharma (NASDAQ:NVCT) with a Buy and maintains $21 price...

Nuvectis Pharma Initiates NXP900 Phase 1a ...
09/12/2023 12:02:14

Nuvectis Pharma, Inc. (NASDAQ:NVCT) ("Nuvectis" or the "Company"), a clinical-stage biopharmaceutical company ...

The FDA Has Granted Orphan Drug Designatio...
08/17/2023 12:02:18

10-short-squeeze-stocks-to-watch-blue-apron-intuitive-machines-yellow-corp-getty-images-and-more

10 Short Squeeze Stocks To Watch: Blue Apr...
08/14/2023 14:49:47

Potential short squeeze plays gained steam in 2021, continued throughout 2022, and remain a new focus of traders looking for th...

Nuvectis Pharma Q2 EPS $(0.38) Misses $(0....
08/09/2023 12:33:12

Nuvectis Pharma (NASDAQ:NVCT) reported quarterly losses of $(0.38) per share which missed the analyst consensus estimate of $(0...

insiders-buying-texas-capital-bancshares-and-3-other-stocks

Insiders Buying Texas Capital Bancshares A...
07/28/2023 13:56:12

Although U.S. stocks closed lower on Thursday, there were a few notable insider trades.

insiders-buying-steel-connect-and-2-other-stocks

Insiders Buying Steel Connect And 2 Other ...
07/21/2023 12:39:50

Although US stocks closed mixed on Thursday, there were a few notable insider trades.